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Objective: To deﬁne how the catabolic cytokines (Interleukin 1 (IL-1) and tumor necrosis factor alpha
(TNFa)) affect the circadian clock mechanism and the expression of clock-controlled catabolic genes
within cartilage, and to identify the downstream pathways linking the cytokines to the molecular clock
within chondrocytes.
Methods: Ex vivo cartilage explants were isolated from the Cry1-luc or PER2::LUC clock reporter mice.
Clock gene dynamics were monitored in real-time by bioluminescence photon counting. Gene expression
changes were studied by qRT-PCR. Functional luc assays were used to study the function of the core
Clock/BMAL1 complex in SW-1353 cells. NFкB pathway inhibitor and ﬂuorescence live-imaging of
cartilage were performed to study the underlying mechanisms.
Results: Exposure to IL-1b severely disrupted circadian gene expression rhythms in cartilage. This effect
was reversed by an anti-inﬂammatory drug dexamethasone, but not by other clock synchronizing agents.
Circadian disruption mediated by IL-1b was accompanied by disregulated expression of endogenous
clock genes and clock-controlled catabolic pathways. Mechanistically, NFкB signalling was involved in the
effect of IL-1b on the cartilage clock in part through functional interference with the core Clock/BMAL1
complex. In contrast, TNFa had little impact on the circadian rhythm and clock gene expression in
cartilage.
Conclusion: In our experimental system (young healthy mouse cartilage), we demonstrate that IL-1b (but
not TNFa) abolishes circadian rhythms in Cry1-luc and PER2::LUC gene expression. These data implicate
disruption of the chondrocyte clock as a novel aspect of the catabolic responses of cartilage to pro-
inﬂammatory cytokines, and provide an additional mechanism for how chronic joint inﬂammation
may contribute to osteoarthritis (OA).
© 2015 The Authors. Published by Elsevier Ltd and Osteoarthritis Research Society International. This is
an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Introduction
The circadian (24 hourly) clocks in the brain and periphery direct
key aspects of physiology through rhythmic control of tissue-
speciﬁc sets of downstream genes1,2. Circadian disruption (e.g.,
during ageing) contributes to various disease states2. Core clock
genes build an auto-regulatory feedback loop, including activators: Q.J. Meng, Faculty of Life
g, Oxford Road, Manchester,
762.
(Q.J. Meng).
r Ltd and Osteoarthritis Research S(Bmal1 and Clock), repressors (Pers and Crys) and output genes (e.g.,
Rev-erbs, Dbp and Nﬁl3)1,2. Articular cartilage that covers the end of
long bones comprises an abundant extracellularmatrix (ECM) and a
sparse population of chondrocytes which are essential for produc-
ing, assembling and turning over the ECM3. Progressive degenera-
tion and destruction of articular cartilage is a common feature of
various forms of arthritis, including rheumatoid arthritis (RA) and
osteoarthritis (OA). We and other groups have previously reported
functional circadian clocks in chondrocytes that control key mole-
cules in the catabolic and anabolic pathways4e6. OA is the most
prevalent joint disease and has a complex aetiology. Ageing,ociety International. This is an open access article under the CC BY license (http://
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OA7. We have demonstrated that the circadian oscillations in carti-
lage becomedamped during ageing, and that the expression of clock
genes in cartilage changes during the initiation stage of OA devel-
opment in an experimental mouse OA model4. Therefore, the
disruption to cartilage rhythms could be an important contributing
factor for the pathogenesis of OA8. It is currently unknown, however,
how ageing and mechanical injuries disrupt cartilage clock rhythm.
Recent evidence strongly suggests that the chronic low grade
inﬂammation that accumulates with age may drive the early degen-
eration during the development of OA, as well as in the late stage
cartilage destruction9e11. In aged, injured and OA joints, levels of pro-
inﬂammatory and catabolic cytokines, e.g., Interleukin 1 (IL-1) and
tumor necrosis factor alpha (TNFa) in the synovial cavity are elevated
in both animal models and humans, with signs of synovitis9,10. These
pro-inﬂammatory cytokines not only elicit catabolic effects (e.g.,
through induction of IL-6, Adamts4, MMPs which lead to matrix
breakdown), but also suppress the anabolic pathways (such as Sox9
and Col2a1 expression), hence further impairing tissue repair9e11.
Application of IL-1b and TNFa alters clock gene expression in
synovial ﬁbroblasts from RA and OA patients12,13. No studies have
examined, however, how these catabolic cytokines impact on the
clocks in cartilage. Given the circadian control of cartilage tissue
homeostasis, we hypothesized that the build-up of pro-
inﬂammatory cytokines may disrupt circadian rhythms in carti-
lage, which then compromises tissue homeostasis and predisposes
cartilage to damage. We tested this hypothesis using cartilageFig. 1. IL-1b and LPS (but not TNFa) disrupt chondrocyte clock. Representative Cry1-luc b
(A) Circadian rhythm in Cry1-luc activity is abolished by IL-1b (5 ng/mL) and LPS (1 mg/mL).
LPS. Light blue arrow: application of Dexamethasone (Dex, 100 nM). (B, C) Treatment with T
Data were normalized to ease visualization. N ¼ 6 animals per group.tissue explants treated with pro-inﬂammatory stimuli and found
that IL-1b profoundly disrupted circadian rhythms in the expres-
sion of clock genes. This effect involves interactions between NFкB
signalling and the core clock mechanism. Interestingly, we also
identiﬁed an unexpected lack of effect of TNFa in regulating
circadian pathways and NFкB signalling in normal cartilage explant.
Materials and methods
Reagents and antibodies
IL-1b and TNFa were purchased from R&D, lipopolysaccharides
(LPS), BMS-345541, dexamethasone (Dex), Forskolin (FSK) were
purchased from Sigma. mClock and hBMAL1 expression plasmids
were kind gifts from Dr. Kazuhiro Yagita (Kyoto Prefectural Uni-
versity of Medicine, Japan).mAvp-luc plasmid and its E-box mutant
form, and luc assay were described previously14,15. Plasmid trans-
fections for SW-1353 cells were performed using Polyfect (Qiagen)
according to the manufacturer's instructions.
Animal maintenance
All animal experiments were conducted under the aegis of the
1986 Home Ofﬁce Animal Procedures Act (UK) and following local
ethical review. Cry1-luc mice were previously described16. In this
transgenic mouse line, the endogenous Cry1 promoter is fused with
a luciferase reporter, allowing real-time monitoring of the Cry1ioluminescent traces from xiphoid cartilage explants under real-time photon counting.
N ¼ 4e6 animals per group. Red or blue arrow indicates time of treatment for IL-1b or
NFa (up to 20 ng/mL) has little effect on Cry1-luc or PER2::LUC oscillation in cartilage.
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were kindly provided by Professor J. Takahashi (the University of
Texas Southwestern Medical Center). In this knock-in mouse,
endogenous PER2 protein is fused in-frame with a luciferase re-
porter17. 8e12 weeks old mice were maintained at 20e22C, on
standard rodent breeder or maintenance chow. Mice were
entrained to a 12 h light and 12 h dark (LD) cycle.
Cartilage explant cultures and bioluminescence recording
Cartilage cultures from clock reporter mice were prepared by
dissection of the cartilaginous portion of the xiphoid process, or by
dissection of the femoral head cartilage from 2 to 4 weeks old
mice4. Cartilage was cultured on 0.4-mm cell culture inserts (Mil-
lipore), and bioluminescence was recorded in real time using a
LumiCycle apparatus (Actimetrics). Baseline subtraction was car-
ried out using a 24-h moving average. For cytokine treatment
studies in cartilage tissue explants18, cartilage tissues were cultured
under LumiCycle recording. After 2e3 days, cytokines were applied.
For the effects of NFкB pathway inhibitors, tissues were pretreated
with these drugs 15 min prior to cytokine treatment. For Dex and
FSK, tissues were treated with cytokines ﬁrst, immediately fol-
lowed by Dex or FSK. The treatment agent was left continuously
with the samples thereafter while the luminescence patterns were
recorded for at least 7 days.
SW-1353 cell culture
The SW-1353 chondrocyte-like cells19 used herein constitu-
tively overexpress Sox9 to drive Col2a1 expression and maintain aFig. 2. Glucocorticoid, but not forskolin (FSK), blocks the inﬂammatory disruption of th
per group). Co-treatment with either Dex and IL-1b in (A), or Dex and LPS in (B), preserves
Co-treatments with FSK (10 mM) and IL-1b or FSK and LPS failed to synchronize the disrup
amplitude before treatment to ease visualization. White arrow: time of treatment.chondrocyte-like phenotype. Cells were cultured in the following
medium, DMEM with 4.5 g/L glucose, Glutamax and pyruvate,
supplemented with 10% FBS, 100 U/mL Penicillin and 100 mg/mL
streptomycin. Cultures were maintained at 37C (5% CO2).
Gene expression analysis
Ribonucleic acid (RNA) was extracted from cartilage explants or
cultured SW-1353 cells using the Qiagen RNeasy puriﬁcation sys-
tem. cDNA was prepared using the Superscript II reverse tran-
scriptase (Invitrogen) and analysed for gene expression using
quantitative real-time PCR with TaqMan (Applied Biosystems)
chemistry. Probeset was ordered (pre-validated) from Applied
Biosystems and described previously4,15. The ﬂuorescence was
recorded from cycle 2 with the linear phase being between cycles
12 and 34. Each sample was run in triplicate. The data were ana-
lysed using the 2DDCT method. To calculate a relative change the
average of the 3 replicate Ct values for each sample was used.
Live tissue imaging
Articular or xiphoid cartilage tissue from p65-DsRed mouse was
embedded in the Matrigel matrix (BD Biosciences) in 35-mm glass
bottom Cellview dishes (Greiner Bio-one). Images were acquired
with a Zeiss LSM 780 Confocal Inverted Microscope in a humidiﬁed
CO2 incubator (at 37C, 5% CO2) with a C-Apochromat 40/1.2 W
Korr objective. During imaging tissue was treated with IL-1b
(5e20 ng/Ml) or TNFa (up to 40 ng/mL). DsRedXP tagged p65 was
visualized by excitation with a green helium neon laser (543 nm)
and detection through both a 545-nm dichroic mirror and a 560-e cartilage clock. Representative Cry1-luc traces from xiphoid cartilage (N ¼ 5 animals
circadian rhythm in Cry1-luc oscillation. Dex, 100 nM; IL-1b, 5 ng/mL; LPS, 1 mg/mL. (C)
ted circadian rhythms in Cry1-luc oscillation. Data were normalized according to the
B. Guo et al. / Osteoarthritis and Cartilage 23 (2015) 1981e19881984nm long pass ﬁlter. Data capture was performed using ZEN2010B
software (Zeiss).
Statistical analysis
Datawere evaluated using Student's t test. Results are presented
as mean ± 95% conﬁdence interval from at least three independent
experiments.
Results
IL-1b but not TNFa disrupts the rhythmic expression of circadian
clock genes in cartilage
We previously demonstrated robust circadian clocks in carti-
lages from the PER2::Luc fusion-protein reporter mouse4. Given the
intimate links between the clock gene Crys and inﬂammation20,21,
we took advantage of the newly generated Cry1-luc16 circadian
reporter mouse, which allowed us to track the dynamics of E-box-
driven Cry1 activity in ex vivo cartilage explants over 7e14 days.We
have shown that cartilages from different anatomical locations
(e.g., xiphoid, femoral head cartilage or knee cartilage) demonstrate
little difference in their circadian oscillations4. Preliminary exper-
iments also revealed similar responses of these different cartilages
to cytokines (Fig. S1). Therefore, xiphoid cartilage tissue was used
as a convenient and more amenable model in most of the subse-
quent studies.
Cartilage explants demonstrated robust circadian oscillations in
Cry1-luc expression, with 24.3 ± 0.3 h period, indicating Cry1 as a
robust rhythmic gene in cartilage tissue [Fig. 1(A)]. To investigate aFig. 3. NFкB signalling is involved in the IL-1b -mediated clock disruption in cartilage. (A
reporter mice was abolished by IL-1b (5 ng/mL), but rescued by pre-treatment with an IKK1
group. Arrow: time of treatment. (B) Differential effects of IL-1b and TNFa on the nuclear tran
cartilage tissue was performed by confocal microscopy. Rapid nuclear translocation of p6
treatment with TNFa at varying concentration (up to 40 ng/mL) and duration (up to 5 h) hrole of pro-inﬂammatory cytokines on cartilage clocks, we treated
cartilage explants with IL-1b, lipopolysaccharides (LPS, a bacterial
product that triggers strong inﬂammatory response), or TNFa. IL-1b
and LPS treatments dampened circadian Cry1-luc bioluminescence
rhythms, and this was associated with a constitutively lower
expression level of Cry1-luc [Fig. 1(A)]. In contrast, treatment with
TNFa had little effect on overall Cry1-luc expression or its circadian
oscillation [Fig. 1(B)]. To investigate whether the lack of response to
TNFa is speciﬁc for Cry1-luc gene dynamics, we treated cartilage
from PER2::LUC mouse with TNFa. Here, similar lack of effect was
observed [Fig. 1(C)], revealing a differential role of IL-1b and TNFa
in cartilage, at least for the clock-related pathways.
Cytokine-mediated disruption of the circadian clock in cartilage can
be blocked by dexamethasone, but not by forskolin
The disruption of circadian gene expression triggered by IL-1b or
LPS was reversible because later application of dexamethasone, an
anti-inﬂammatory agent, restored the overall level and oscillatory
amplitude of the damped circadian rhythm [Fig. 1(A)]. Further, co-
application of Dex with IL-1b or LPS effectively maintained the
circadian oscillation of the cartilage explants [Fig. 2(A), (B)]. Inter-
estingly, neither IL-1b nor LPS had any discernible effects on the
circadian oscillations in tissue explants from lung or oesophagus
(data not shown), suggesting a cartilage tissue-speciﬁc mechanism.
These results reveal disruption of circadian clock in cartilage as a
new target of the pro-inﬂammatory and catabolic cytokines.
The cytokine-induced disruption of circadian rhythmicity could
be due to a population-level desynchronization of the constituent
oscillatory cells within the tissue. Alternatively, it may reﬂect) Circadian rhythm in xiphoid cartilage explants from either the Cry1-luc or PER2::LUC
/2 inhibitor (BMS 345531, 10 mM). Representative result was shown, N ¼ 4 animals per
slocation of NFкB in mouse femoral head cartilage. Imaging of p65-DsRedXP expressing
5-DsRed was observed within 40 min of IL-1b treatment (5e20 ng/mL). In contrast,
ad little discernible effect. Representative data were shown, N ¼ 3 animals per group.
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clock oscillator. Given that Dex has both anti-inﬂammatory effects
and clock-resetting actions in peripheral tissues, including carti-
lage4,22, these alternative hypotheses could not be differentiated. To
address whether desynchrony of cellular clocks might play a role in
the damping of the rhythm, cartilages were treatedwith forskolin, a
known clock-synchronizing agent. This increased the oscillatory
amplitude of the control cartilage by ~2.5 fold [Fig. 2(C)]. Co-
application of either IL-1b or LPS with forskolin, however, failed
to rescue the disrupted clocks [Fig. 2(C)], i.e., imposed synchroni-
sation could not rescue the disruptive effect of the cytokines. These
results indicate that a clock-desynchronizing effect is unlikely to be
the main mechanism for the cytokine-mediated disruption of
cartilage rhythm: rather a compromise of the cell-autonomous
circadian mechanism is more likely.
IL-1b-mediated disruption of the circadian clock in cartilage
involves NFкB signalling
One of the classic downstream pathways for pro-inﬂammatory
cytokines is through NFкB signalling. Upon cytokine treatments,
activation of IKK leads to phosphorylation and subsequent degra-
dation of IкBa, thereby releasing NFкB, which then translocates to
the nucleus to modulate its target genes24. Indeed, in the current
study pre-treatment with the IKK1/2 inhibitor BMS-345541 pre-
vented the loss of circadian rhythmicity in the IL-1b treated carti-
lage explants from both the Cry1-luc and the PER2::LUC reporter
mice. It also partially restored the level of Cry1-luc or PER2::LUC
expression, indicating the involvement of the NFкB pathway
[Fig. 3(A)]. Finally, in young WT mouse femoral head or xiphoid
cartilage tissues expressing the p65-DsRedXP protein fusion
construct25, IL-1b treatment elicited rapid (within 40 min) nuclearFig. 4. Changes of clock genes and catabolic pathway-related genes upon IL-1b treatme
Following clock synchronization, tissue explants were treated with IL-1b (5 ng/mL) 4 h befor
of parallel Cry1-luc cartilages). Tissues were then removed at the relative peak of Cry1-luc
normalized to b-actin. To calculate a relative change the average of the 3 replicate CT value
group.translocation of p65, one of the main NFкB subunits [Fig. 3(B),
Fig. S2]. In contrast, in cartilages treated with various doses of TNFa
(up to 40 ng/mL), p65 remained largely cytoplasmic. These results
favour the hypothesis that NFкB signalling is a mediator linking
selective inﬂammatory signals to the dysregulation of the chon-
drocyte clock, and identiﬁed a differential response of cartilage
NFкB signalling to IL-1b and TNFa.
IL-1b simultaneously affects the clock genes and catabolic pathways
To test the alternative hypothesis, we investigated the effect of
treatment with IL-1b on the expression of endogenous clock genes
in cartilage explants. Consistent with the reduced Cry1-luc
expression, IL-1b treatment (for 4 h) signiﬁcantly reduced the Cry1
and Cry2 mRNA levels in cartilage (Fig. 4). Cry genes are positively
regulated by the core Clock/BMAL1 complex through E-box cis el-
ements in their promoters. Consistently, we found down-regulation
of several other classic E-box regulated clock genes, including Dbp,
Nr1d1, Per1 and Per2 upon IL-1b treatment (Fig. 4, Fig. S3). In
contrast, TNFa had little effect on the expression of the above
endogenous clock genes (Fig. S4). Interestingly, the expression of
the clock gene Nﬁl3 (with known functions in inﬂammation and
negatively regulated by NR1D123) showed signiﬁcant up-regulation
upon IL-1b treatment (Fig. 4). Of note is that Dbp and Nﬁl3 are two
clock output genes that have opposing roles in regulating down-
stream clock target genes that contain D-box cis-regulatory se-
quences. The opposite changes of these two clock outputs suggest a
dysregulation of a spectrum of D-box containing cartilage genes.
We have previously shown that several catabolic pathway
related genes in cartilage are clock-controlled4, such as Mmp14 (a
membrane-associated proteinase), Timp4 (tissue inhibitor of MMP,
member 4), and Adamts4 (a major cytokine-inducible aggrecanase).nt in cartilage explants. Cartilage explant cultures were synchronized by FSK (10 mM).
e the corresponding peak of Cry1-luc expression (judged by bioluminescence recording
activity for total RNA extraction. mRNA levels were quantiﬁed by Q-PCR. Data were
s for each sample was used. Mean ± 95% conﬁdence interval; t test, n ¼ 6 animals per
B. Guo et al. / Osteoarthritis and Cartilage 23 (2015) 1981e19881986Consistent with the changes of clock genes, IL-1b treatment
signiﬁcantly increased Mmp14 and Adamts4 expression, while
suppressing Timp4 levels [Fig. 4, (P) < 0.01 for all three genes].
These results suggest the possibility that changes of clock genes
may be involved in linking cytokine signalling to the catabolic
pathways within cartilage. As a control, we also measured two
catabolic genesMMP13 and IL-6, which are well established targets
of NFкB. Consistent with the potent nuclear translocation of p65
induced by IL-1b, signiﬁcant increase of MMP13 and IL-6 expres-
sion was observed (Fig. 4).IL-1b treatment interferes with the function of the core clock
complex
The down-regulation of E-box controlled clock genes suggests
that IL-1b may disrupt the function of the core clock mechanism,
i.e., the Clock/BMAL1-mediated transactivation of E-box elements.
To dissect the molecular mechanism of the cytokine-mediated
circadian disruption further, we performed functional promoter-
luc assays in a SW-1353 chondrocyte-like cell line using a well-
established E-box-containing Avp gene promoter-luc construct14.
Co-expression of Clock and BMAL1 signiﬁcantly increased the
wild-type Avp-luc activity, but not that of the E-box mutated
control plasmid. In SW-1353 cells treated with IL-1b, the ability of
Clock/BMAL1 to transactivate the E-box promoter was signiﬁcantly
reduced [P < 0.01 at 1 h and P < 0.05 at 4 h, Fig. 5(A)]. Pre-
treatment with the IKK1/2 inhibitor BMS-345541 partially
blocked the suppressive effect of IL-1b on E-box activation, sup-
porting a role of NFкB signalling in mediating the dampened clock
function upon IL-1b treatment [Fig. 5(B)]. In contrast, treatmentFig. 5. IL-1b supresses the Clock/BMAL1 activation of E-box element in an NFкB-depend
1353 cells. Data (mean ± 95% conﬁdence interval) was normalised to b-galactosidase reporte
Each experiment was repeated at least three times.(A, B) Expression plasmids for Clock and
1353 cells. Cells were then treated with IL-1b (5 ng/mL for 1 or 4 h), with or without pretreat
assay. (C) As above, the effect of TNFa (10 ng/mL for 4 h) on the Clock/BMAL1 transactivatiwith TNFa had little effect on E-box transactivation [Fig. 5(C),
(P) > 0.05], consistent with a lack of effect of this cytokine on clock
gene oscillation. These results suggest that inﬂammatory cytokines
may have cell-type speciﬁc roles in regulating their downstream
targets and that IL-1b interferes with canonical circadian tran-
scriptional mechanisms.Discussion
Our ﬁndings using cartilage tissue explants from the clock re-
porter mouse models identify the disruption of the circadian clock
in cartilage as a novel target for joint inﬂammation. Given the
diverse pathways controlled by the cartilage circadian clock, the
profound disruption of clock genes may be involved in driving key
aspects of the catabolic response of cartilage to chronic joint
inﬂammation.
Cross-talk between inﬂammation/immune response and the
circadian system has been reported in other tissues26e29. For
example, in macrophages and synovial ﬁbroblasts, the Clock/
NFкB interaction impedes the formation of the Clock/BMAL1
complex26. Consequently, activation of NFкB signalling leads to
suppression of clock function in those cell types. To the best of
our knowledge, this study is the ﬁrst to demonstrate an unam-
biguous role of inﬂammation to circadian rhythms in clock gene
expression in cartilage tissue. Clock disruption in synovial tissue/
cells has been reported in arthritic diseases12,13. Although, in
those studies, the low resolution sampling and the absence of
healthy tissue samples for comparison render the conclusions
tentative. In contrast, our study using long-term real-time
monitoring of clock gene dynamics provides ex vivo evidenceent manner in human chondrocyte-like cells. Representative luc assay results in SW-
r gene and expressed relative to control. t test, N ¼ 4 culture replicates per experiment.
BMAL1 were co-expressed with Avp-luc promoter (wt or E-box mutant form) in SW-
ment with BMS 345531 (10 mM). Following cytokine incubation, cells were lysed for luc
on of wt Avp-luc promoter was evaluated.
B. Guo et al. / Osteoarthritis and Cartilage 23 (2015) 1981e1988 1987that the cartilage tissue clock is a sensitive target for inﬂamma-
tory cytokines.
We also identiﬁed a differential response of cartilage clocks to
IL-1b and TNFa under normal (non-arthritic) conditions. It is likely
that within the joint tissue, IL-1 has a predominant role in
disruption of the cartilage clock and thus on matrix breakdown,
while TNFa targets clocks in other cell types, such as the synovial
cells or immune cells, as reported before26,29. The ﬁnding that TNFa
is not capable of driving NFкB nuclear translocation in normal
cartilage is intriguing. Both IL-1 and TNFa have well established
roles in both RA and OA9e11. The downstream signalling cascades
and targets within cartilage tissue and chondrocytes are, however,
likely to diverge. For example, microarray studies in SW-1353 cells
revealed distinct target gene clusters in response to IL-1 or TNFa19.
Catabolic genes like IL-6, BMP-2, MMP13 and COX-2 only respond
to IL-1, with signiﬁcantly lower or no response to TNFa19,30. We
were able to replicate the differential effects of IL-1 and TNFa on
human IL-6 induction in SW-1353 cells (Fig. S5). Of note is that
mouse and human chondrocytes are known to express receptors
for TNFa31,32. Consistent with previous reports, our own RNAseq
results in mouse hip cartilage (unpublished) andmicroarray results
in mouse xiphoid cartilage4 reveal that the transcript levels for
TNFR1(TNFrsf1a) and IL-1R1 are readily detectible (Fig. S6). How-
ever, cytokine receptors are known to be differentially regulated
during OA33. Therefore, it is not unlikely that arthritic chondrocytes
become sensitive to TNFa. Moreover, the elevated levels of both
TNFa and IL-1 in OA joints may have synergizing effects. Further
investigation is clearly needed to assess how the circadian clocks in
OA chondrocytes respond to these catabolic cytokines.
The novel concept of disruption of the circadian clock of carti-
lage as a new target of joint inﬂammation is signiﬁcant because
currently there is no disease-modifying therapy available for OA.
Various anti-inﬂammation strategies have been proposed for OA,
some of which (e.g., IL-1Ra therapies) are in clinical trials/use for
limiting degradation of cartilage in RA and OA. So far, these tradi-
tional anti-inﬂammatory drugs are generally less effective in OA
than in RA, and less well tolerated in the elderly OA patients. Our
ﬁndings may provide new routes to combat chronic joint inﬂam-
mation in OA patients, e.g., targeting the circadian clock itself by
clock acting compounds34e36, which could be combined with the
conventional anti-inﬂammatory drugs to reduce their dosage and,
hence, their adverse effects.
In conclusion, we have demonstrated that IL-1b, but not TNFa,
profoundly disrupts clock gene rhythms in ex vivo cartilage ex-
plants, and this effect involves NFкB signalling. Our data highlight
disruption of the chondrocyte clock as a novel target for the re-
sponses of cartilage to pro-inﬂammatory/catabolic cytokines, and
provide an additional mechanism for how chronic joint inﬂam-
mation contributes to OA.Author contributions
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